Small, Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 17, 2024
Extensive accumulation of senescent cells contributes to organismal aging, and slowing down the process cellular senescence may ameliorate age-related pathologies. Targeted inhibition mechanistic target rapamycin complex 1 (mTORC1) is found suppress conversion senescence. The regulatory-associated protein mTOR (Raptor), a key component mTORC1, has been implicated as important in aging process, its druggability deserves be investigated. Due high efficiency convenience drug construction, siRNA shows great potential silencing Raptor expression via RNA interfering therapy. Here, we developed functionalized anti-aging nanoplatform based on tetrahedral DNA nanostructures (TDNs) encapsulating targeting for synergistic therapy, named siR-TDN
Language: Английский